Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry

The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions

(2010) Farnaz Hasteh et al.   CANCER CYTOPATHOLOGY

Usefulness of EMA, GLUT-1, and XIAP for the Cytologic Diagnosis of Malignant Mesothelioma in Body Cavity Fluids

(2009) Jian Shen et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Differentiating reactive mesothelial cells from metastatic adenocarcinoma in serous effusions: The utility of immunocytochemical panel in the differential diagnosis

(2009) Husain A. Saleh et al.   DIAGNOSTIC CYTOPATHOLOGY

A Useful Antibody Panel for Differential Diagnosis Between Peritoneal Mesothelioma and Ovarian Serous Carcinoma in Japanese Cases

(2008) Yukio Takeshima et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Cytopathologic differential diagnosis of malignant mesothelioma, adenocarcinoma and reactive mesothelial cells: A logistic regression analysis

(2008) Ebru Cakir et al.   DIAGNOSTIC CYTOPATHOLOGY

The value of calretinin and cytokeratin 56 as markers for mesothelioma in cell block preparations of serous effusions

(2007) P. W. Shield et al.   CYTOPATHOLOGY